GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 203 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q2 2018. The put-call ratio across all filers is 0.35 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $10,775,000 | +119.2% | 158,222 | +31.2% | 0.01% | +150.0% |
| Q1 2021 | $4,915,000 | -18.1% | 120,623 | -12.9% | 0.00% | -20.0% |
| Q4 2020 | $5,999,000 | -18.6% | 138,517 | +3.7% | 0.01% | -28.6% |
| Q3 2020 | $7,367,000 | -10.7% | 133,612 | +2.2% | 0.01% | -12.5% |
| Q2 2020 | $8,251,000 | +25.1% | 130,706 | +1.3% | 0.01% | 0.0% |
| Q1 2020 | $6,593,000 | -49.7% | 129,052 | -21.8% | 0.01% | -33.3% |
| Q4 2019 | $13,118,000 | +136.5% | 165,032 | +44.4% | 0.01% | +100.0% |
| Q3 2019 | $5,546,000 | +83.3% | 114,311 | +98.7% | 0.01% | +50.0% |
| Q2 2019 | $3,026,000 | +19.4% | 57,524 | +20.2% | 0.00% | +33.3% |
| Q1 2019 | $2,534,000 | +27.1% | 47,867 | -1.4% | 0.00% | 0.0% |
| Q4 2018 | $1,994,000 | 0.0% | 48,567 | -7.4% | 0.00% | 0.0% |
| Q3 2018 | $1,994,000 | -23.5% | 52,467 | -9.0% | 0.00% | -25.0% |
| Q2 2018 | $2,606,000 | +598.7% | 57,645 | +646.9% | 0.00% | +300.0% |
| Q1 2018 | $373,000 | -7.7% | 7,718 | -24.8% | 0.00% | 0.0% |
| Q4 2017 | $404,000 | – | 10,262 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 356,270 | $24,262,000 | 23.36% |
| Twin Securities, Inc. | 376,669 | $25,651,000 | 11.94% |
| Paradigm Biocapital Advisors LP | 1,175,879 | $80,077,000 | 10.68% |
| Chicago Capital Management, LLC | 246,246 | $16,769,000 | 9.12% |
| HARVEST MANAGEMENT LLC | 141,500 | $9,636,000 | 7.78% |
| Fernwood Investment Management, LLC | 174,724 | $11,899,000 | 5.02% |
| ArchPoint Investors | 168,725 | $11,490,000 | 4.69% |
| HAVENS ADVISORS LLC | 46,000 | $3,133,000 | 4.69% |
| Perceptive Advisors | 2,322,247 | $158,145,000 | 4.59% |
| Crabel Capital Management, LLC | 112,680 | $7,674,000 | 4.48% |